Bone drug reveals hidden strength: study shows structure improves even when density Doesn't
NCT ID NCT01155232
First seen May 14, 2026 · Last updated May 14, 2026
Summary
This study looks at how teriparatide, a bone-building drug, affects the inner structure of bones in 100 men and women with osteoporosis over 24 months. Researchers use a special 3D scanner to see changes in bone thickness and shape at the wrist and shin, beyond just bone density. The goal is to better understand how the drug strengthens bones and reduces fracture risk.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOPOROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Health Network, TGH
Toronto, Ontario, M5G 2C4, Canada
Conditions
Explore the condition pages connected to this study.